Sentry Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,653
Closed -$365K 363
2025
Q4
$365K Hold
14,653
0.24% 80
2025
Q3
$376K Sell
14,653
-3,598
-20% -$88.8K 0.25% 75
2025
Q2
$468K Hold
18,251
0.26% 76
2025
Q1
$413K Buy
18,251
+13,290
+268% +$348K 0.28% 71
2024
Q4
$132K Sell
4,961
-22,364
-82% -$607K 0.06% 253
2024
Q3
$791K Hold
27,325
0.33% 60
2024
Q2
$765K Sell
27,325
-5,597
-17% -$154K 0.34% 55
2024
Q1
$914K Buy
32,922
+15,272
+87% +$424K 0.35% 61
2023
Q4
$508K Sell
17,650
-15,131
-46% -$457K 0.22% 116
2023
Q3
$1.09M Sell
32,781
-6,876
-17% -$243K 0.52% 34
2023
Q2
$1.46M Buy
39,657
+43
+0.1% +$1.67K 0.55% 31
2023
Q1
$1.62M Buy
39,614
+2,271
+6% +$98.1K 0.67% 25
2022
Q4
$1.91M Sell
37,343
-1,211
-3% -$58.1K 0.84% 23
2022
Q3
$1.69M Hold
38,554
0.8% 20
2022
Q2
$2.02M Sell
38,554
-6,969
-15% -$355K 0.91% 17
2022
Q1
$2.36M Sell
45,523
-7,067
-13% -$367K 0.75% 21
2021
Q4
$3.1M Buy
52,590
+1,360
+3% +$67.4K 0.82% 15
2021
Q3
$2.2M Sell
51,230
-8,369
-14% -$371K 0.64% 24
2021
Q2
$2.33M Hold
59,599
0.59% 27
2021
Q1
$2.16M Sell
59,599
-400,695
-87% -$14.2M 0.6% 31
2020
Q4
$16.9M Sell
460,294
-24,158
-5% -$886K 0.85% 20
2020
Q3
$16.9M Sell
484,452
-108
-0% -$3.79K 0.94% 19
2020
Q2
$15M Sell
484,560
-1,861
-0.4% -$63.2K 0.91% 19
2020
Q1
$15.1M Buy
486,421
+117,373
+32% +$4M 1.11% 15
2019
Q4
$13.7M Hold
369,048
0.82% 21
2019
Q3
$12.6M Buy
369,048
+3,424
+0.9% +$125K 0.82% 25
2019
Q2
$15M Buy
365,624
+3,519
+1% +$140K 0.99% 15
2019
Q1
$14.6M Sell
362,105
-43,456
-11% -$1.74M 1.01% 17
2018
Q4
$16.8M Sell
405,561
-10,436
-3% -$433K 1.22% 11
2018
Q3
$17.4M Sell
415,997
-3,525
-0.8% -$136K 1.06% 13
2018
Q2
$14.4M Sell
419,522
-44,068
-10% -$1.51M 0.94% 17
2018
Q1
$15.6M Sell
463,590
-42,804
-8% -$1.47M 0.95% 14
2017
Q4
$17.4M Sell
506,394
-201
-0% -$6.85K 0.95% 17
2017
Q3
$17.2M Buy
506,595
+2,196
+0.4% +$70.6K 0.64% 24
2017
Q2
$16.1M Buy
504,399
+5,033
+1% +$159K 0.63% 25
2017
Q1
$16.2M Sell
499,366
-24,512
-5% -$773K 0.66% 25
2016
Q4
$16.1M Buy
523,878
+5,313
+1% +$162K 0.68% 25
2016
Q3
$16.7M Buy
518,565
+16,565
+3% +$554K 0.73% 23
2016
Q2
$16.8M Sell
502,000
-2,353
-0.5% -$75.1K 0.73% 22
2016
Q1
$14.2M Buy
504,353
+1,744
+0.3% +$49.8K 0.64% 24
2015
Q4
$15.4M Buy
502,609
+123,494
+33% +$3.89M 0.71% 23
2015
Q3
$11.3M Sell
379,115
-18,808
-5% -$603K 0.56% 31
2015
Q2
$12.7M Sell
397,923
-76,954
-16% -$2.51M 0.59% 27
2015
Q1
$15.7M Buy
474,877
+8,432
+2% +$268K 0.74% 19
2014
Q4
$13.8M Buy
466,445
+50,878
+12% +$1.46M 0.67% 24
2014
Q3
$11.7M Buy
415,567
+22,079
+6% +$620K 0.6% 26
2014
Q2
$11.1M Buy
393,488
+253
+0.1% +$7.21K 0.57% 25
2014
Q1
$12M Sell
393,235
-7,905
-2% -$236K 0.63% 21
2013
Q4
$11.7M Sell
401,140
-155,676
-28% -$4.53M 0.63% 21
2013
Q3
$15.2M Buy
556,816
+89,139
+19% +$2.43M 0.9% 15
2013
Q2
$12.4M Buy
+467,677
New +$12.9M 0.72% 14

Other funds holding PFE

Sentry Investment Management's PFE Position: Q1 2026 in Review

Sentry Investment Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 14,653 shares — an estimated $365K sold.

Sentry Investment Management first reported a position in PFE in Q2 2013 and held it in 51 quarters. The position peaked at $17.4M in Q4 2017. 2,955 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Sentry Investment Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Sentry Investment Management sold 14,653 Pfizer shares in Q1 2026, an estimated $365K.
  • Sentry Investment Management first reported a position in Pfizer in Q2 2013 and held it in 51 quarters.
  • Sentry Investment Management's Pfizer position peaked at $17.4M in Q4 2017.
  • 2,955 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.